Mithramycin A

Mithramycin A

$120.00 - 1 mg

$420.00 - 5 mg

All prices in Australian dollars

Code
BIA-M1268
Synonyms
Aureolic acid, Mithracin, Plicamycin, Mitramycin, A 2371, LA 7017, NSC 23559, PA 144
CAS #
18378-89-7
Molecular Formula
C52H76O24
Molecular Weight
1085.2
Purity
>95% by HPLC
Long Term Storage
-20°C
Solubility
Soluble in ethanol, methanol, DMF or DMSO. Limited water solubility.

Download Data Sheets

Product Data Sheet

Application Notes

Mithramycin A was the first of the aureolic acid class of antitumor antibiotics, isolated from Streptomyces. Mithramycin inhibits transcription and protein synthesis by non-covalent binding with G-C-rich duplex DNA in the presence of magnesium and zinc ions. Mithramycin also induces differentiation of leukemic cells accompanied by an early decrease in c-myc expression, and selectively inhibits collagen-1 gene expression in human fibroblasts.

References

  • Aureolic acid, a new antibiotic. I. Microbiological studies. Grundy W. E. et al., Antibiot. Chemother. 1953, 2, 1215.
  • Aureolic acid group of anti-tumor antibiotics. Berlin Y. U. et al., Nature 1968, 218, 193.
  • Mithramycin selectively inhibits the transcriptional activity of a transfected human c-myc gene Ray R. et al., Am. J. Med. Sci. 1990, 300, 203.
  • Mithramycin selectively inhibits collagen-alpha 1(I) gene expression in human fibroblast. Nehls M. C. et al., ; J. Clin. Invest. 1993, 92, 2916

Other Products

Related products